Showing results (51-60 of 72) with videos related to
Sort By:
Pageof 8
European Journal of Pharmacology|May 19, 2009
Pharmacological characterization of the nociceptin/orphanin FQ receptor non peptide antagonist Compound 24Carmela Fischetti, Valeria Camarda, Anna Rizzi, et al.The Journal of Pharmacology and Experimental Therapeutics|October 31, 2008
In vitro and in vivo pharmacological characterization of the neuropeptide s receptor antagonist [D-Cys(tBu)5]neuropeptide SValeria Camarda, Anna Rizzi, Chiara Ruzza, et al.Naunyn-Schmiedeberg'S Archives of Pharmacology|June 19, 2002
Pharmacological characterisation of [(pX)Phe4]nociceptin(1-13)amide analogues. 1. In vitro studiesRaffaella Bigoni, Daniela Rizzi, Anna Rizzi, et al.Naunyn-Schmiedeberg'S Archives of Pharmacology|June 19, 2002
Pharmacological characterisation of [(pX)Phe4]nociceptin(1-13)NH2 analogues. 2. In vivo studiesAnna Rizzi, Maria Bonaria Salis, Roberto Ciccocioppo, et al.Journal of Medicinal Chemistry|December 31, 2008
Synthesis and biological activity of human neuropeptide S analogues modified in position 5: identification of potent and pure neuropeptide S receptor antagonistsRemo Guerrini, Valeria Camarda, Claudio Trapella, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 14, 2012
Lack of a chemobrain effect for adjuvant FOLFOX chemotherapy in colon cancer patients. A pilot studyFederica Andreis, Marco Ferri, Maria Mazzocchi, et al.Peptides|May 29, 2007
In vitro and in vivo studies on UFP-112, a novel potent and long lasting agonist selective for the nociceptin/orphanin FQ receptorAnna Rizzi, Barbara Spagnolo, Richard D Wainford, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 30, 2004
Blockade of nociceptin/orphanin FQ receptor signaling in rat substantia nigra pars reticulata stimulates nigrostriatal dopaminergic transmission and motor behaviorMatteo Marti, Flora Mela, Carlo Veronesi, et al.Bioorganic & Medicinal Chemistry|June 17, 2009
Structure-activity studies on the nociceptin/orphanin FQ receptor antagonist 1-benzyl-N-{3-[spiroisobenzofuran-1(3H),4'-piperidin-1-yl]propyl} pyrrolidine-2-carboxamideClaudio Trapella, Carmela Fischetti, Michela Pela', et al.British Journal of Pharmacology|April 25, 2014
Pharmacological characterization of tachykinin tetrabranched derivativesChiara Ruzza, Anna Rizzi, Davide Malfacini, et al.Pageof 8